Progyny, Inc. (PGNY)
Sector: Services-Misc Health & Allied Services, NEC
Industry: Medical - Healthcare Plans
Progyny, Inc.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 6, 2026 | 33.67 | 34.90 | 33.34 | 34.84 | 1,550,908 |
| Nov 5, 2026 | 33.17 | 35.50 | 32.03 | 34.37 | 2,790,552 |
| Nov 4, 2026 | 29.39 | 30.73 | 28.80 | 30.10 | 1,244,789 |
| Nov 3, 2026 | 29.67 | 29.71 | 28.95 | 29.06 | 1,028,192 |
| Nov 2, 2026 | 29.26 | 29.76 | 29.10 | 29.41 | 1,351,206 |
| Oct 30, 2026 | 28.66 | 29.22 | 28.30 | 29.19 | 807,727 |
| Oct 29, 2026 | 28.03 | 28.58 | 28.03 | 28.40 | 657,470 |
| Oct 28, 2026 | 27.55 | 28.43 | 27.55 | 27.87 | 543,204 |
| Oct 27, 2026 | 28.10 | 28.34 | 27.61 | 27.72 | 923,762 |
| Oct 26, 2026 | 28.97 | 29.25 | 28.12 | 28.13 | 650,929 |
| Oct 23, 2026 | 29.06 | 29.11 | 28.80 | 28.97 | 565,860 |
| Oct 22, 2026 | 28.59 | 29.24 | 28.47 | 29.12 | 744,612 |
| Oct 21, 2026 | 28.55 | 28.74 | 28.26 | 28.44 | 712,710 |
| Oct 20, 2026 | 28.03 | 28.95 | 28.03 | 28.58 | 1,233,747 |
| Oct 19, 2026 | 26.77 | 27.86 | 26.75 | 27.84 | 782,041 |
| Oct 16, 2026 | 27.65 | 27.78 | 26.74 | 26.86 | 919,574 |
| Oct 15, 2026 | 27.77 | 28.41 | 27.43 | 27.45 | 1,057,256 |
| Oct 14, 2026 | 27.26 | 28.05 | 27.26 | 27.84 | 774,076 |
| Oct 13, 2026 | 28.22 | 28.82 | 27.26 | 27.39 | 1,061,573 |
| Oct 12, 2026 | 27.88 | 28.17 | 27.64 | 28.03 | 825,987 |
| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
 Livingston Mark S. | CHIEF FINANCIAL OFFICER | Sale | 2.1K | $64.2K | Nov 4, 2026 |
 Swartz Allison | EVP, GC | Grant/Award | 11.4K | -- | Nov 2, 2026 |
| Swartz Allison | EVP, GC | Grant/Award | 8.2K | -- | Nov 2, 2026 |
 Cummings Melissa B | Chief Operating Officer | Sale | 1.9K | $52.6K | Oct 14, 2026 |
| Cummings Melissa B | Chief Operating Officer | Automatic Sell | 1.6K | $42.7K | Oct 14, 2026 |
| Swartz Allison | EVP, GC | Sale | 3.9K | $101.9K | Sep 23, 2026 |
| Name | Shares | % | Source |
|---|---|---|---|
BlackRock, Inc. | 11.6M | 15.8% | 13F |
BlackRock, Inc. · also on 13F· may incl. warrants· filed Oct 2026 | 11.3M | 15.3% | 13G |
FMR LLC | 7.0M | 9.5% | 13F |
FMR LLC · also on 13F· joint filing· may incl. warrants· filed Aug 2026 | 7.0M | 9.5% | 13G |
THRIVENT FINANCIAL FOR LUTHERANS · also on 13F· may incl. warrants· filed Apr 2025 | 5.4M | 7.3% | 13G |
VANGUARD PORTFOLIO MANAGEMENT LLC | 5.0M | 6.8% | 13F |
VANGUARD CAPITAL MANAGEMENT LLC | 3.2M | 4.4% | 13F |
STATE STREET CORP | 3.0M | 4.1% | 13F |
AMERIPRISE FINANCIAL INC | 2.8M | 3.8% | 13F |
GEODE CAPITAL MANAGEMENT, LLC | 2.5M | 3.4% | 13F |
Insiders
- Livingston Mark S.CHIEF FINANCIAL OFFICER
- Swartz AllisonEVP, GC
- Cummings Melissa BChief Operating Officer
- Clapp GeoffreyChief Product Officer
- GORDON KEVIN KDirector
- Anevski PeterCHIEF EXECUTIVE OFFICER
- Scott CherylDirector
- Bierbower Elizabeth DDirector
- Dean Lloyd HDirector
- HOLSTEIN ROGER CDirector
Progyny, Inc. functions as a benefits management corporation, dedicated to providing specialized solutions for fertility and broader family-building initiatives to employers throughout the United States.
Its core fertility offering is characterized by a distinctive benefits plan architecture, paired with personalized, white-glove member support services and access to a meticulously chosen network of top-tier fertility specialists.
Additionally, the company presents Progyny Rx, an all-encompassing pharmacy benefits solution that ensures its members can readily acquire the essential medications for their treatments. Moreover, Progyny facilitates employer-sponsored reimbursement programs to support surrogacy and adoption journeys.
The company, which was established in 2008 and has its main offices in New York City, previously operated as Auxogyn, Inc. before adopting the Progyny, Inc. moniker in 2015.
13F filers report 77.38M shares, more than the 73.65M outstanding, so no percentage is shown. 13F reports lag by a quarter and shares lent to short sellers can be counted twice.
US30d Avg
1.01M
60d Avg
1.13M
90d Avg
1.10M